Back to top

Image: Bigstock

Has BioCardia (BCDA) Outpaced Other Medical Stocks This Year?

Read MoreHide Full Article

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has BioCardia, Inc. (BCDA - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

BioCardia, Inc. is a member of the Medical sector. This group includes 1184 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. BioCardia, Inc. is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for BCDA's full-year earnings has moved 0.7% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Our latest available data shows that BCDA has returned about 6.2% since the start of the calendar year. Meanwhile, stocks in the Medical group have lost about 17.5% on average. This means that BioCardia, Inc. is outperforming the sector as a whole this year.

Another Medical stock, which has outperformed the sector so far this year, is Ensign Group (ENSG - Free Report) . The stock has returned 6.5% year-to-date.

For Ensign Group, the consensus EPS estimate for the current year has increased 0.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

To break things down more, BioCardia, Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 557 individual companies and currently sits at #70 in the Zacks Industry Rank. On average, this group has lost an average of 21.6% so far this year, meaning that BCDA is performing better in terms of year-to-date returns.

In contrast, Ensign Group falls under the Medical - Nursing Homes industry. Currently, this industry has 2 stocks and is ranked #27. Since the beginning of the year, the industry has moved +3.1%.

Investors interested in the Medical sector may want to keep a close eye on BioCardia, Inc. and Ensign Group as they attempt to continue their solid performance.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

The Ensign Group, Inc. (ENSG) - free report >>

BioCardia, Inc. (BCDA) - free report >>

Published in